BLP25 liposomal synthetic MUC-1 vaccine: Phase I

Biomira Inc. (TSE:BRA; BIOMF), Edmonton, Alberta Product: BLP25 liposomal synthetic MUC-1 vaccine Indication: Treat non-small cell lung cancer Status: BIOMF completed enrollment of 14 patients in its ...